These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
377 related articles for article (PubMed ID: 16037278)
1. Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesis. Kim W; Hudson BI; Moser B; Guo J; Rong LL; Lu Y; Qu W; Lalla E; Lerner S; Chen Y; Yan SS; D'Agati V; Naka Y; Ramasamy R; Herold K; Yan SF; Schmidt AM Ann N Y Acad Sci; 2005 Jun; 1043():553-61. PubMed ID: 16037278 [TBL] [Abstract][Full Text] [Related]
2. The RAGE axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyond. Ramasamy R; Yan SF; Schmidt AM Trends Cardiovasc Med; 2005 Oct; 15(7):237-43. PubMed ID: 16226677 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications. Yan SF; Ramasamy R; Schmidt AM Nat Clin Pract Endocrinol Metab; 2008 May; 4(5):285-93. PubMed ID: 18332897 [TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end product receptor-mediated cellular dysfunction. Bierhaus A; Humpert PM; Stern DM; Arnold B; Nawroth PP Ann N Y Acad Sci; 2005 Jun; 1043():676-80. PubMed ID: 16037292 [TBL] [Abstract][Full Text] [Related]
5. Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging. Yan SF; D'Agati V; Schmidt AM; Ramasamy R Curr Mol Med; 2007 Dec; 7(8):699-710. PubMed ID: 18331228 [TBL] [Abstract][Full Text] [Related]
6. RAGE: a multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation. Schmidt AM; Hofmann M; Taguchi A; Yan SD; Stern DM Semin Thromb Hemost; 2000; 26(5):485-93. PubMed ID: 11129404 [TBL] [Abstract][Full Text] [Related]
7. Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury. Soulis T; Thallas V; Youssef S; Gilbert RE; McWilliam BG; Murray-McIntosh RP; Cooper ME Diabetologia; 1997 Jun; 40(6):619-28. PubMed ID: 9222639 [TBL] [Abstract][Full Text] [Related]
8. Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond. Yan SF; Ramasamy R; Naka Y; Schmidt AM Circ Res; 2003 Dec; 93(12):1159-69. PubMed ID: 14670831 [TBL] [Abstract][Full Text] [Related]
9. Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes. Shoji T; Koyama H; Morioka T; Tanaka S; Kizu A; Motoyama K; Mori K; Fukumoto S; Shioi A; Shimogaito N; Takeuchi M; Yamamoto Y; Yonekura H; Yamamoto H; Nishizawa Y Diabetes; 2006 Aug; 55(8):2245-55. PubMed ID: 16873687 [TBL] [Abstract][Full Text] [Related]
10. Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis. Ihara Y; Egashira K; Nakano K; Ohtani K; Kubo M; Koga J; Iwai M; Horiuchi M; Gang Z; Yamagishi S; Sunagawa K J Mol Cell Cardiol; 2007 Oct; 43(4):455-64. PubMed ID: 17761193 [TBL] [Abstract][Full Text] [Related]
11. Endogenous secretory receptor for advanced glycation end-products and cardiovascular disease in end-stage renal disease. Nishizawa Y; Koyama H J Ren Nutr; 2008 Jan; 18(1):76-82. PubMed ID: 18089449 [TBL] [Abstract][Full Text] [Related]
12. RAGE, vascular tone and vascular disease. Farmer DG; Kennedy S Pharmacol Ther; 2009 Nov; 124(2):185-94. PubMed ID: 19616578 [TBL] [Abstract][Full Text] [Related]
13. RAGE: a journey from the complications of diabetes to disorders of the nervous system - striking a fine balance between injury and repair. Rong LL; Gooch C; Szabolcs M; Herold KC; Lalla E; Hays AP; Yan SF; Yan SS; Schmidt AM Restor Neurol Neurosci; 2005; 23(5-6):355-65. PubMed ID: 16477098 [TBL] [Abstract][Full Text] [Related]
14. RAGE axis: Animal models and novel insights into the vascular complications of diabetes. Naka Y; Bucciarelli LG; Wendt T; Lee LK; Rong LL; Ramasamy R; Yan SF; Schmidt AM Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1342-9. PubMed ID: 15155381 [TBL] [Abstract][Full Text] [Related]
16. Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury. Zhou Z; Wang K; Penn MS; Marso SP; Lauer MA; Forudi F; Zhou X; Qu W; Lu Y; Stern DM; Schmidt AM; Lincoff AM; Topol EJ Circulation; 2003 May; 107(17):2238-43. PubMed ID: 12719284 [TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end products and receptor-oxidative stress system in diabetic vascular complications. Yamagishi S Ther Apher Dial; 2009 Dec; 13(6):534-9. PubMed ID: 19954478 [TBL] [Abstract][Full Text] [Related]
18. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. Yamamoto Y; Kato I; Doi T; Yonekura H; Ohashi S; Takeuchi M; Watanabe T; Yamagishi S; Sakurai S; Takasawa S; Okamoto H; Yamamoto H J Clin Invest; 2001 Jul; 108(2):261-8. PubMed ID: 11457879 [TBL] [Abstract][Full Text] [Related]
19. Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes. Gu L; Hagiwara S; Fan Q; Tanimoto M; Kobata M; Yamashita M; Nishitani T; Gohda T; Ni Z; Qian J; Horikoshi S; Tomino Y Nephrol Dial Transplant; 2006 Feb; 21(2):299-313. PubMed ID: 16263740 [TBL] [Abstract][Full Text] [Related]